Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

IOVAIOVA

Showing 8 of 30 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in IOVANCE BIOTHERAPEUTICS INC

Yes. BNP Paribas Financial Markets holds 105,837 shares of IOVA (Iovance Biotherapeutics), worth $440,282, as of its Q2 2026 13F filing. It reduced the position by 267,302 shares (-71.6%) from Q1 2026. BNP Paribas Financial Markets has held IOVA since Q1 2019, across 30 quarterly 13F filings.

Current Value

$440,282

Current Shares

105,837

Total Value Change

-$627,586

Total Shares Change

-7,887

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
105,837
-71.6%
$440,2820.0%$4.16
0
2026-Q1
Increased
373,139
+1293.0%
$1.3M0.0%$3.51
41
2025-Q4
Decreased
26,787
-50.7%
$73,1290.0%$2.73
0
2025-Q3
Increased
54,353
+30.6%
$117,9460.0%$2.17
28
2025-Q2
Increased
41,623
+79.8%
$71,5920.0%$1.72
22
2025-Q1
Decreased
23,152
-56.5%
$77,0960.0%$3.33
0
2024-Q4
Decreased
53,281
-53.1%
$394,2790.0%$7.40
0
2024-Q3
Decreased
113,724
-75.5%
$1.1M0.0%$9.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used